β‐Blocker Therapy Prior to Admission for Acute Coronary Syndrome in Patients Without Heart Failure or Left Ventricular Dysfunction Improves In‐Hospital and 12‐Month Outcome: Results From the GULF‐RACE 2 (Gulf Registry of Acute Coronary Events‐2)

BACKGROUND: The prognostic impact of β‐blockers (BB) in acute coronary syndrome (ACS) patients without heart failure (HF) or left ventricular dysfunction is controversial, especially in the postreperfusion era. We sought to determine whether a BB therapy before admission for ACS has a favorable in‐h...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Am Heart Assoc
Hoofdauteurs: Abi Khalil, Charbel, AlHabib, Khalid F., Singh, Rajvir, Asaad, Nidal, Alfaleh, Hussam, Alsheikh‐Ali, Alawi A., Sulaiman, Kadhim, Alshamiri, Mostafa, Alshaer, Fayez, AlMahmeed, Wael, Al Suwaidi, Jassim
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2017
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5779059/
https://ncbi.nlm.nih.gov/pubmed/29263035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.007631
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items